|
Volumn 60, Issue 21, 2000, Pages 6089-6094
|
Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin θ(I) 1
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY CONJUGATE;
CALICHEAMICIN DERIVATIVE;
CALICHEAMICIN THETA1;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY 138H11;
MONOCLONAL ANTIBODY CH14.18;
TECHNETIUM 99M;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER IMMUNOTHERAPY;
CONTROLLED STUDY;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG TARGETING;
FEMALE;
HUMAN;
HUMAN CELL;
ISOTOPE LABELING;
KIDNEY CARCINOMA;
MOUSE;
NONHUMAN;
NUDE MOUSE;
PRIORITY JOURNAL;
AMINOGLYCOSIDES;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIBODIES, MONOCLONAL;
BODY WEIGHT;
CARCINOMA, RENAL CELL;
ENEDIYNES;
FEMALE;
GAMMA-GLUTAMYLTRANSFERASE;
HUMANS;
IMMUNOTOXINS;
KIDNEY NEOPLASMS;
MICE;
MICE, NUDE;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0034326838
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (23)
|
References (29)
|